Oncternal Therapeutics, Inc. (ONCT)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 25.88M |
| Enterprise Value | -8.05M |
| Trailing P/E | 2.11 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.86 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.19 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.37 |
| 52-Week Change 3 | 32.42% |
| S&P500 52-Week Change 3 | 22.43% |
| 52 Week High 3 | 13.20 |
| 52 Week Low 3 | 5.57 |
| 50-Day Moving Average 3 | 8.82 |
| 200-Day Moving Average 3 | 7.77 |
Share Statistics
| Avg Vol (3 month) 3 | 7.77k |
| Avg Vol (10 day) 3 | 3.7k |
| Shares Outstanding 5 | 2.96M |
| Implied Shares Outstanding 6 | 2.96M |
| Float 8 | 2.68M |
| % Held by Insiders 1 | 9.23% |
| % Held by Institutions 1 | 15.24% |
| Shares Short (Apr 15, 2024) 4 | 13.8k |
| Short Ratio (Apr 15, 2024) 4 | 1.72 |
| Short % of Float (Apr 15, 2024) 4 | 0.50% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.47% |
| Shares Short (prior month Mar 15, 2024) 4 | 15k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jun 10, 2019 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:20 |
| Last Split Date 3 | Jan 08, 2024 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -3,244.44% |
Management Effectiveness
| Return on Assets (ttm) | -49.48% |
| Return on Equity (ttm) | -86.75% |
Income Statement
| Revenue (ttm) | 785k |
| Revenue Per Share (ttm) | 0.27 |
| Quarterly Revenue Growth (yoy) | 73.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -39.48M |
| Diluted EPS (ttm) | -13.43 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 34.26M |
| Total Cash Per Share (mrq) | 11.57 |
| Total Debt (mrq) | 318k |
| Total Debt/Equity (mrq) | 1.06% |
| Current Ratio (mrq) | 6.94 |
| Book Value Per Share (mrq) | 10.19 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -32.16M |
| Levered Free Cash Flow (ttm) | -19.38M |
© 2024 Yahoo. All rights reserved.